Syndrome of Inappropriate Antidiuretic Hormone Secretion Causes and Diagnosis

Small cell lung cancer is the most frequent malignant cause of SIADH, occurring in approximately 10-45% of SCLC cases, though only 1-5% develop symptomatic SIADH, and the tumor cells directly produce arginine vasopressin (ADH), creating a paraneoplastic syndrome, according to the American Thoracic Society 1
Non-small cell lung cancer occurs in approximately 0.7% of cases, with squamous cell carcinoma and adenocarcinoma both capable of producing ADH, as reported by the American College of Chest Physicians 1
Hyponatremia in SCLC patients is associated with shortened survival, making early detection critical, as stated by the American College of Chest Physicians 1

Medication-Induced SIADH

Multiple drug classes are well-established causes of SIADH through stimulation of inappropriate ADH release, including platinum-based chemotherapy, vinca alkaloids, cyclophosphamide, and melphalan, as well as psychotropic medications such as SSRIs, SNRIs, carbamazepine, and oxcarbazepine, according to the European Society of Medical Oncology 2
The concurrent use of multiple CNS agents or combining thiazide diuretics with SIADH-inducing medications substantially increases risk, as warned by the European Society of Medical Oncology 2
NSAIDs and opioids can also cause SIADH, as reported by the European Society of Medical Oncology 2

Non-malignant pulmonary conditions are important causes of SIADH, including pulmonary infections such as pneumonia and tuberculosis, as stated by the European Respiratory Society 1

CNS disorders cause SIADH through disruption of normal hypothalamic-pituitary function and ADH regulation, including CNS infections, space-occupying lesions, subarachnoid hemorrhage, and other neurological diseases, as reported by the American Academy of Neurology 4
Neuroimaging with CT or MRI is essential to identify structural lesions such as ring-enhancing abscesses with surrounding edema, as recommended by the American Academy of Neurology 4

SIADH must be distinguished from cerebral salt wasting (CSW), particularly in neurosurgical patients, as they require opposite management approaches, as stated by the American Academy of Neurology 2
A serum uric acid level <4 mg/dL in the presence of hyponatremia has a positive predictive value for SIADH of 73-100%, as reported by the European Society of Medical Oncology 2
Adrenal insufficiency and hypothyroidism must be excluded before diagnosing SIADH, as these conditions can mimic the syndrome, as recommended by the Endocrine Society 1